Bvf Inc Elevation Oncology, Inc. Call Options Transaction History
Bvf Inc
- $3.15 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ELEV
# of Institutions
70Shares Held
41.9MCall Options Held
700Put Options Held
27.6K-
Frazier Life Sciences Management, L.P. Menlo Park, CA5.99MShares$3.84 Million0.19% of portfolio
-
Tang Capital Management LLC San Diego, CA4.76MShares$3.05 Million0.24% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.53MShares$2.26 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY2.83MShares$1.81 Million0.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.61MShares$1.67 Million0.0% of portfolio
About Elevation Oncology, Inc.
- Ticker ELEV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,300,900
- Market Cap $14.9M
- Description
- Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...